000 01597 a2200445 4500
005 20250517170038.0
264 0 _c20180723
008 201807s 0 0 eng d
022 _a2038-3312
024 7 _a10.1007/s13304-017-0480-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuadagni, Stefano
245 0 0 _aMitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
_h[electronic resource]
260 _bUpdates in surgery
_cSep 2017
300 _a403-410 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacokinetics
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aChemotherapy, Cancer, Regional Perfusion
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoxia
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMitomycin
_xpharmacokinetics
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPelvis
650 0 4 _aRectal Neoplasms
_xdrug therapy
700 1 _aFiorentini, Giammaria
700 1 _aClementi, Marco
700 1 _aPalumbo, Paola
700 1 _aMambrini, Andrea
700 1 _aMasedu, Francesco
773 0 _tUpdates in surgery
_gvol. 69
_gno. 3
_gp. 403-410
856 4 0 _uhttps://doi.org/10.1007/s13304-017-0480-6
_zAvailable from publisher's website
999 _c27449381
_d27449381